Merck Settles State Vioxx Probes, to Pay $58 Million
pharmiweb.co.uk     20-May-2008            

NEW YORK (Reuters) - Merck & Co Inc said on Tuesday it will pay $58 million to settle state investigations into its withdrawn pain drug Vioxx. The payment, to be shared by 29 states and the District of Columbia, resolves previously disclosed probes under state consumer protection laws related to... [read full story]                    


View all news articles about*:
Analgesics Anti-inflammatory KGaA Medication Medicines Merck Pharmaceuticals Remedies
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Intercell's partner Merck initiates Phase II study of bacterial vaccine

pharmiweb.co.uk     yesterday          

Datamonitor Pharmaceutical and HealthWire - Aug. 28, 2008 Austria-based biotechnology company Intercell has announced that its collaborator Merck & Co has initiated a Phase II clinical trial of V710, an investigational...                    

comments

                   

Cervical cancer advances give hope to poor

mirror.co.uk     yesterday   5 related          

By Michael Kahn, LONDON (Reuters) 28/08/2008 New screening tests and effective vaccines from Merck & Co and GlaxoSmithKline make tackling cervical cancer in poor countries a real possibility for the first time, researchers...                    

comments

                   

Pain Therapeutics, King Pharma develop abuse-resistant pain medication

pharmiweb.co.uk     10 hrs ago   3 related          

San Mateo, California Pain Therapeutics, Inc. and King Pharmaceuticals, Inc. announced they are developing a new abuse-resistant prescription pain medication called PTI-721. Like Remoxy (controlled-release oxycodone),...                    

comments

Albemarle to Increase Ibuprofen Prices

prnewswire.com     yesterday          

BATON ROUGE, La., Aug. 28 /PRNewswire-FirstCall/ -- Specialty chemicals maker Albemarle Corporation (NYSE: ALB), a leading global manufacturer of the anti-inflammatory agent ibuprofen, will increase the prices for its...                    

comments